11/5/2020 7:06:44 AM
Teva Q3 Non-GAAP EPS $0.58
10/21/2020 8:04:57 AM
Teva Collaborates With Amazon Web Services And Onica To Build And Host Digital Health Platform
10/5/2020 8:04:48 AM
Teva Canada Announces Availability Of Aermony RespiClick, Available In Three Dose Options
10/2/2020 8:04:08 AM
Teva Reports Availability Of First FDA-approved Generic Versions Of TRUVADAi And ATRIPLAi Tablets
9/21/2020 8:09:18 AM
Teva Launches Two Digital Inhalers In The U.S.
9/15/2020 8:15:25 AM
Teva Says Results From 52-week, Parallel Group Study Evaluating AJOVY Injection Published In Neurology
9/8/2020 8:06:04 AM
Teva To Present New Data On AUSTEDO Tablets At MDS Virtual Congress 2020 And Psych Congress 2020 Virtual Experience
8/25/2020 9:02:14 PM
Federal Grand Jury In Philadelphia, Pennsylvania
returns Criminal Indictment Charging Teva USA
8/19/2020 8:02:45 AM
Teva Canada Announces Product Availability Of AJOVY 225 Mg Solution
8/18/2020 10:49:27 AM
Teva Sued By U.S. Over Alleged Kickbacks For Multiple Sclerosis Drug
8/5/2020 7:15:55 AM
Teva, Alvotech Enter Into Strategic Partnership For Commercialization In U.S. Of Five Biosimilar Product Candidates